Literature DB >> 33941600

Post-acute sequelae of SARS-CoV-2 infection: Caring for the 'long-haulers'.

Susan Vehar1, Marina Boushra2, Prince Ntiamoah3, Michelle Biehl3.   

Abstract

An estimated 10% of COVID-19 survivors continue to experience symptoms several weeks to months after the appearance of initial symptoms, a condition termed post-acute sequelae of SARS-CoV-2 infection (PASC). These patients, also called "long-haulers," most commonly report protracted symptoms of fatigue, cough, dyspnea, chest tightness, difficulty concentrating, arthralgia, olfactory dysfunction, and headache. While age, comorbid medical conditions, and COVID-19 severity are risk factors, young and previously healthy individuals with mild COVID-19 are also at risk. Recognition of symptoms, evaluation, supportive treatment, and attention to medical comorbidities are the cornerstones of medical management.
Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

Entities:  

Year:  2021        PMID: 33941600     DOI: 10.3949/ccjm.88a.21010

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  13 in total

Review 1.  Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.

Authors:  Doris Loh; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

2.  Long-Term Effects of COVID-19 and the Pandemic on Tinnitus Patients.

Authors:  Murat Erinc; Ahmet Mutlu; Serdal Celik; Mahmut Tayyar Kalcioglu; Agnieszka J Szczepek
Journal:  Front Neurol       Date:  2022-06-30       Impact factor: 4.086

3.  Cardiovascular symptom phenotypes of post-acute sequelae of SARS-CoV-2.

Authors:  Zainab Mahmoud; Lauren East; Marye Gleva; Pamela K Woodard; Kory Lavine; Amanda K Verma
Journal:  Int J Cardiol       Date:  2022-07-13       Impact factor: 4.039

4.  Indomethacin for refractory COVID or post-COVID headache: a retrospective study.

Authors:  Abouch V Krymchantowski; Raimundo Pereira Silva-Néto; Carla Jevoux; Ana Gabriela Krymchantowski
Journal:  Acta Neurol Belg       Date:  2021-09-21       Impact factor: 2.471

5.  COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment.

Authors:  Stephanie A Richard; Simon D Pollett; Charlotte A Lanteri; Eugene V Millar; Anthony C Fries; Ryan C Maves; Gregory C Utz; Tahaniyat Lalani; Alfred Smith; Rupal M Mody; Anuradha Ganesan; Rhonda E Colombo; Christopher J Colombo; David A Lindholm; Cristian Madar; Sharon Chi; Nikhil Huprikar; Derek T Larson; Samantha E Bazan; Caroline English; Edward Parmelee; Katrin Mende; Eric D Laing; Christopher C Broder; Paul W Blair; Josh G Chenoweth; Mark P Simons; David R Tribble; Brian K Agan; Timothy H Burgess
Journal:  Open Forum Infect Dis       Date:  2021-11-10       Impact factor: 3.835

6.  Severe respiratory viral infections in children with history of asymptomatic or mild COVID-19.

Authors:  Nooralam Rai; Joseph A Cornett; Philip Zachariah; Lynne Quittell; Stephanie Lovinsky-Desir
Journal:  Pediatr Pulmonol       Date:  2021-11-15

Review 7.  Post-acute sequelae of COVID-19 and the mental health implications.

Authors:  Namrata Walia; Jessica Olivia Lat; Rabeet Tariq; Surbhi Tyagi; Adam Manzoor Qazi; Syeda Wajiha Salari; Amina Jafar; Tasneem Kousar; Sherrie Bieniek
Journal:  Discoveries (Craiova)       Date:  2021-12-31

Review 8.  T Cell Metabolism in Infection.

Authors:  Jonas Aakre Wik; Bjørn Steen Skålhegg
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

Review 9.  COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives.

Authors:  Marianne Lauwers; Manting Au; Shuofeng Yuan; Chunyi Wen
Journal:  Int J Mol Sci       Date:  2022-01-10       Impact factor: 5.923

Review 10.  Molecular and Clinical Prognostic Biomarkers of COVID-19 Severity and Persistence.

Authors:  Gethsimani Papadopoulou; Eleni Manoloudi; Nikolena Repousi; Lemonia Skoura; Tara Hurst; Timokratis Karamitros
Journal:  Pathogens       Date:  2022-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.